Project
Single Cell Drug Screening AI Platform
Our high-throughput single cell drug testing AI platform accelerate cancer research, drug development, and clinical precision.
- Yes
- None
- Equity
- Bio-Tech
- Technology
- Private Project
- R&D Cooperation
- Open for negotiation
- Professional Services
- Minority Shareholdings
- 2,500,001 to 5,000,000 USD
- 1,000,001 to 2,500,000 USD
- Feasibility Study Completed
- Public–private partnership / Concession